All Stories

  1. Validation of the implementation of phased-array heating systems in Plan2Heat
  2. A Novel Framework for Thermoradiotherapy Treatment Planning
  3. Increased human papillomavirus viral load is correlated to higher severity of cervical disease and poorer clinical outcome: A systematic review
  4. Robust, planning-based targeted locoregional tumour heating in small animals
  5. Adjuvant Hyperthermic Intraperitoneal Chemotherapy in Patients With Locally Advanced Colon Cancer (COLOPEC): 5-Year Results of a Randomized Multicenter Trial
  6. Biological treatment evaluation in thermoradiotherapy: application in cervical cancer patients
  7. Perturbation of Copper Homeostasis Sensitizes Cancer Cells to Elevated Temperature
  8. Radiosensitization by hyperthermia critically depends on the time interval
  9. Quantification of tissue property and perfusion uncertainties in hyperthermia treatment planning: Multianalysis using polynomial chaos expansion
  10. Delivering Energy using Localized Hyperthermia Systems
  11. Impact of Short-Course Palliative Radiation Therapy on Pancreatic Cancer-Related Pain: Prospective Phase 2 Nonrandomized PAINPANC Trial
  12. Application of HIPEC simulations for optimizing treatment delivery strategies
  13. Quantitative analysis of contribution of mild and moderate hyperthermia to thermal ablation and sensitization of irreversible electroporation of pancreatic cancer cells
  14. OC-0100 Short course radiation improves pain from pancreatic cancer: A prospective phase II study (NTR5143)
  15. Elevated temperatures and longer durations improve the efficacy of oxaliplatin- and mitomycin C-based hyperthermic intraperitoneal chemotherapy in a confirmed rat model for peritoneal metastasis of colorectal cancer origin
  16. The Relevance of High Temperatures and Short Time Intervals Between Radiation Therapy and Hyperthermia: Insights in Terms of Predicted Equivalent Enhanced Radiation Dose
  17. Validation of thermal dynamics during Hyperthermic IntraPEritoneal Chemotherapy simulations using a 3D-printed phantom
  18. Evaluation of thermal dose effect in radiofrequency-induced hyperthermia with intravesical chemotherapy for nonmuscle invasive bladder cancer
  19. Fixed vs Targeted Protocol during CT-guided IRE in Locally Advanced and Recurrent Pancreatic Cancer Following Induction Chemotherapy: A Randomized Phase II Trial
  20. Hyperthermia as a Potential Cornerstone of Effective Multimodality Treatment with Radiotherapy, Cisplatin and PARP Inhibitor in IDH1-Mutated Cancer Cells
  21. Comparison of the clinical performance of a hybrid Alba 4D and the AMC-4 locoregional hyperthermia systems
  22. A patterns of care analysis of hyperthermia in combination with radio(chemo)therapy or chemotherapy in European clinical centers
  23. Biological modeling in thermoradiotherapy: present status and ongoing developments toward routine clinical use
  24. Deep learning DCE-MRI parameter estimation: Application in pancreatic cancer
  25. Validation and practical use of Plan2Heat hyperthermia treatment planning for capacitive heating
  26. Non-Invasive Imaging and Scoring of Peritoneal Metastases in Small Preclinical Animal Models Using Ultrasound: A Preliminary Trial
  27. A scalable hyperthermic intravesical chemotherapy (HIVEC) setup for rat models of bladder cancer
  28. A randomized phase-II study of reirradiation and hyperthermia versus reirradiation and hyperthermia plus chemotherapy for locally recurrent breast cancer in previously irradiated area
  29. Adhesion formation after surgery for locally advanced colonic cancer in the COLOPEC trial
  30. Adapt2Heat: treatment planning-assisted locoregional hyperthermia by on-line visualization, optimization and re-optimization of SAR and temperature distributions
  31. Post-operative re-irradiation with hyperthermia in locoregional breast cancer recurrence: Temperature matters
  32. A scalable setup for hyperthermic intravesical chemotherapy in rodents
  33. Improving Prediction of the Potential Distribution Induced by Cylindrical Electrodes within a Homogeneous Rectangular Grid during Irreversible Electroporation
  34. Clinical Evidence for Thermometric Parameters to Guide Hyperthermia Treatment
  35. The role of hyperthermia in the treatment of locally advanced cervical cancer: a comprehensive review
  36. Combined Use of wIRA and Microwave or Radiofrequency Hyperthermia
  37. Fast Adaptive Temperature-Based Re-Optimization Strategies for On-Line Hot Spot Suppression during Locoregional Hyperthermia
  38. Hyperthermia Treatment Planning: Clinical Application and Ongoing Developments
  39. SP-0340 Biological rationale for combining heat and radiation
  40. Preclinical In Vivo-Models to Investigate HIPEC; Current Methodologies and Challenges
  41. Improved unsupervised physics‐informed deep learning for intravoxel incoherent motion modeling and evaluation in pancreatic cancer patients
  42. Creating a cumulative equivalent thermal isoeffect dosimetry model in several ex vivo tissue models mimicking focal laser ablation treatment of the prostate
  43. PARP1-Inhibition Sensitizes Cervical Cancer Cell Lines for Chemoradiation and Thermoradiation
  44. Hyperthermia-Based Anti-Cancer Treatments
  45. Modulating the Heat Stress Response to Improve Hyperthermia-Based Anticancer Treatments
  46. Simulation of clinical focal laser ablation treatments to create a dosimetry model of the ablation zone using critical CEM43 values
  47. Demonstration of treatment planning software for hyperthermic intraperitoneal chemotherapy in a rat model
  48. Effect of gastrointestinal gas on the temperature distribution in pancreatic cancer hyperthermia treatment planning
  49. Simulating drug penetration during hyperthermic intraperitoneal chemotherapy
  50. Treatment planning facilitates clinical decision making for hyperthermia treatments
  51. Clinical Feasibility of a High-Resolution Thermal Monitoring Sheet for Superficial Hyperthermia in Breast Cancer Patients
  52. A Four-Inflow Construction to Ensure Thermal Stability and Uniformity during Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Rats
  53. HyCHEED System for Maintaining Stable Temperature Control during Preclinical Irreversible Electroporation Experiments at Clinically Relevant Temperature and Pulse Settings
  54. Two high-resolution thermal monitoring sheets for clinical superficial hyperthermia
  55. The Temperature-Dependent Effectiveness of Platinum-Based Drugs Mitomycin-C and 5-FU during Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Colorectal Cancer Cell Lines
  56. Integrating Loco-Regional Hyperthermia Into the Current Oncology Practice: SWOT and TOWS Analyses
  57. Experimental validation of a thermophysical fluid model for use in a hyperthermia treatment planning system
  58. Deep learning‐based reconstruction of in vivo pelvis conductivity with a 3D patch‐based convolutional neural network trained on simulated MR data
  59. Response: Commentary: The Impact of the Time Interval Between Radiation and Hyperthermia on Clinical Outcome in Patients With Locally Advanced Cervical Cancer
  60. Dedicated 70 MHz RF systems for hyperthermia of challenging tumor locations
  61. Modelling Curved Contact Flexible Microstrip Applicators for Patient-Specific Superficial Hyperthermia Treatment Planning
  62. Radiosensitization by Hyperthermia: The Effects of Temperature, Sequence, and Time Interval in Cervical Cell Lines
  63. Hyperthermia treatment planning: clinical application and ongoing research
  64. Loco-regional Hyperthermia Delivery: Patient-specific set-up Procedures for Treatment Optimisation
  65. Heating technology for malignant tumors: a review
  66. Molecular and biological rationale of hyperthermia as radio- and chemosensitizer
  67. Advanced patient-specific hyperthermia treatment planning
  68. Locoregional peritoneal hyperthermia to enhance the effectiveness of chemotherapy in patients with peritoneal carcinomatosis: a simulation study comparing different locoregional heating systems
  69. Mathematical modeling of the thermal effects of irreversible electroporation for in vitro, in vivo, and clinical use: a systematic review
  70. Thermodynamic profiling during irreversible electroporation in porcine liver and pancreas: a case study series
  71. Enhancing the abscopal effect of radiation and immune checkpoint inhibitor therapies with magnetic nanoparticle hyperthermia in a model of metastatic breast cancer
  72. Adjuvant hyperthermic intraperitoneal chemotherapy in patients with locally advanced colon cancer (COLOPEC): a multicentre, open-label, randomised trial
  73. Combining 70MHz and 434MHz or wIRA Hyperthermia Applicators for Optimal Coverage of Semi-Deep Tumour Sites
  74. Transceive phase mapping using the PLANET method and its application for conductivity mapping in the brain
  75. Hyperthermia Treatment Planning Including Convective Flow in Cerebrospinal Fluid for Brain Tumour Hyperthermia Treatment Using a Novel Dedicated Paediatric Brain Applicator
  76. Whole-body hyperthermia in combination with systemic therapy in advanced solid malignancies
  77. The Impact of the Time Interval Between Radiation and Hyperthermia on Clinical Outcome in Patients With Locally Advanced Cervical Cancer
  78. Accuracy and precision of electrical permittivity mapping at 3T: the impact of three mapping techniques
  79. Quality assurance guidelines for interstitial hyperthermia
  80. Variation in Clinical Application of Hyperthermic Intraperitoneal Chemotherapy: A Review
  81. Hyperthermia: The Optimal Treatment to Overcome Radiation Resistant Hypoxia
  82. Temperature and thermal dose during radiotherapy and hyperthermia for recurrent breast cancer are related to clinical outcome and thermal toxicity: a systematic review
  83. Time-dependent impact of irreversible electroporation on pancreas, liver, blood vessels and nerves: a systematic review of experimental studies.
  84. Time-dependent impact of irreversible electroporation on pancreas, liver, blood vessels and nerves: a systematic review of experimental studies
  85. Re‑irradiation plus hyperthermia for recurrent pediatric sarcoma; a simulation study to investigate feasibility
  86. Clinical validation of a novel thermophysical bladder model designed to improve the accuracy of hyperthermia treatment planning in the pelvic region
  87. Professor Gerrit Willem (Eddie) Barendsen, August 14, 1927 – June 20, 2018
  88. The effect of air pockets in the urinary bladder on the temperature distribution during loco-regional hyperthermia treatment of bladder cancer patients
  89. Predictive value of simulated SAR and temperature for changes in measured temperature after phase-amplitude steering during locoregional hyperthermia treatments
  90. RF Heating of Pancreatic Tumours Guided by Hyperthermia Treatment Planning and Limited Thermometry
  91. Technical and Clinical Evaluation of the ALBA-4D 70MHz Loco-Regional Hyperthermia System
  92. Enhancement of Radiation Effectiveness in Cervical Cancer Cells by Combining Ionizing Radiation with Hyperthermia and Molecular Targeting Agents
  93. The alfa and beta of tumours: a review of parameters of the linear-quadratic model, derived from clinical radiotherapy studies
  94. The effect of time interval between radiotherapy and hyperthermia on planned equivalent radiation dose
  95. Analysis of clinical data to determine the minimum number of sensors required for adequate skin temperature monitoring of superficial hyperthermia treatments
  96. Locoregional hyperthermia of deep-seated tumors applied with capacitive and radiative systems: a simulation study
  97. Reirradiation + hyperthermia for recurrent breast cancer en cuirasse
  98. The clinical benefit of hyperthermia in pancreatic cancer: a systematic review
  99. Feasibility of on-line temperature-based hyperthermia treatment planning to improve tumour temperatures during locoregional hyperthermia
  100. Online Adaptive Hyperthermia Treatment Planning During Locoregional Heating to Suppress Treatment-Limiting Hot Spots
  101. Clinical use of a waveguide hyperthermia system for superficial tumors with deep infiltration
  102. Hyperthermia of deep seated pelvic tumors with a phased array of eight versus four 70 MHz waveguides
  103. Thermal Skin Damage During Reirradiation and Hyperthermia Is Time-Temperature Dependent
  104. Development of a 70 MHz unit for hyperthermia treatment of deep-seated breast tumors
  105. Enhancing radiosensitisation of BRCA2-proficient and BRCA2-deficient cell lines with hyperthermia and PARP1-i
  106. Measurement and analysis of the impact of time-interval, temperature and radiation dose on tumour cell survival and its application in thermoradiotherapy plan evaluation
  107. Progress and future directions in hyperthermia treatment planning
  108. Development of electrical properties tomography for hyperthermia treatment planning
  109. A short time interval between radiotherapy and hyperthermia reduces in-field recurrence and mortality in women with advanced cervical cancer
  110. Enhancing synthetic lethality of PARP-inhibitor and cisplatin in BRCA-proficient tumour cells with hyperthermia
  111. A flexible 70 MHz phase-controlled double waveguide system for hyperthermia treatment of superficial tumours with deep infiltration
  112. Colorectal cancer at high risk of peritoneal metastases; long term outcomes of a pilot study on adjuvant laparoscopic HIPEC and future perspectives
  113. Time-dependent impact of irreversible electroporation on pancreas, liver, blood vessels and nerves: a systematic review of experimental studies
  114. Correction: Time-Dependent Impact of Irreversible Electroporation on Pancreas, Liver, Blood Vessels and Nerves: A Systematic Review of Experimental Studies
  115. Planning, optimisation and evaluation of hyperthermia treatments
  116. Sensitizing thermochemotherapy with a PARP1-inhibitor
  117. Quality assurance guidelines for superficial hyperthermia clinical trials
  118. Targeting therapy-resistant cancer stem cells by hyperthermia
  119. Quality assurance guidelines for superficial hyperthermia clinical trials: I. Clinical requirements
  120. A comparison of the heating characteristics of capacitive and radiative superficial hyperthermia
  121. Time-Dependent Impact of Irreversible Electroporation on Pancreas, Liver, Blood Vessels and Nerves: A Systematic Review of Experimental Studies
  122. 3D radiobiological evaluation of combined radiotherapy and hyperthermia treatments
  123. A 70 MHz double waveguide set-up for hyperthermia of deep superficial tumors
  124. Development of a 70 MHz unit for hyperthermia treatment of deep seated breast tumors
  125. Improving hyperthermia treatment planning for the pelvis by accurate fluid modeling
  126. Analysis of enhancement at small and large radiation doses for effectiveness of inactivation in cultured cells by combining two agents with radiation
  127. SU-F-J-05: The Effect of Air Pockets in the Urinary Bladder During Bladder Hyperthermia Treatment
  128. The use of hyperthermia in the treatment of bladder cancer
  129. Thermal dosimetry for bladder hyperthermia treatment. An overview
  130. B1-based SAR reconstruction using contrast source inversion–electric properties tomography (CSI-EPT)
  131. Chemohyperthermia in non-muscle-invasive bladder cancer: An overview of the literature and recommendations
  132. OC-0054: Reirradiation+hyperthermia for recurrent breast canceren-cuirasse in previously irradiated area
  133. PO-0723: Short time interval between radiation and hyperthermia improves treatment outcome in cervical cancer
  134. EP-2024: Optimising hyperthermia induced radiosensitisaion for treating HPV+ cervical tumours
  135. OC-0548: Hyperthermia treatment planning in the pelvis using thermophysical fluid modelling of the bladder
  136. Hyperthermia treatment planning for cervical cancer patients based on electrical conductivity tissue properties acquiredin vivowith EPT at 3 T MRI
  137. Rib fractures after reirradiation plus hyperthermia for recurrent breast cancer
  138. Biological modelling of the radiation dose escalation effect of regional hyperthermia in cervical cancer
  139. In vivoelectric conductivity of cervical cancer patients based on $B_{1}^{+}$ maps at 3T MRI
  140. Thermoradiotherapy planning: Integration in routine clinical practice
  141. Hyperthermia Selectively Targets Human Papillomavirus in Cervical Tumors via p53-Dependent Apoptosis
  142. Combining Mitomycin C and Regional 70 MHz Hyperthermia in Patients with Nonmuscle Invasive Bladder Cancer: A Pilot Study
  143. Local hyperthermia combined with radiotherapy and-/or chemotherapy: Recent advances and promises for the future
  144. Reirradiation and hyperthermia for irresectable locoregional recurrent breast cancer in previously irradiated area: Size matters
  145. Current state of the art of regional hyperthermia treatment planning: a review
  146. A mixed frequency approach to optimize locoregional RF hyperthermia
  147. Development of a 27.12 MHz CC-LCF intraluminal applicator for hyperthermia of the esophagus
  148. CSI-EPT: A Contrast Source Inversion Approach for Improved MRI-Based Electric Properties Tomography
  149. Effects of hyperthermia on DNA repair pathways: one treatment to inhibit them all
  150. Hyperthermia-related clinical trials on cancer treatment within the ClinicalTrials.gov registry
  151. Development of a novel method to enhance the therapeutic effect on tumours by simultaneous action of radiation and heating
  152. SP-0299: Technical aspects of hyperthermia: present and future
  153. EP-1271: Development of focused microwave hyperthermia of pediatric brain cance
  154. EP-1467: Meta-analysis of radiosensitivity and fractionation sensitivity of human tumours
  155. PO-0727: Thermophysical fluid modelling for loco-regional hyperthermia treatment of Non-Muscle Invasive Bladder Cancer
  156. OC-0065: Electrical tissue property imaging in patients using MRI to improve hyperthermia treatment planning
  157. OC-0334: Reirradiation plus hyperthermia for irresectable recurrent breast cancer; size matters
  158. Improved temperature monitoring and treatment planning for loco-regional hyperthermia treatments of Non-Muscle Invasive Bladder Cancer (NMIBC)
  159. P096 Optimization of bladder hyperthermia treatment for non-muscle invasive bladder cancer using loco-regional heating, 3D thermometry and hyperthermia treatment planning
  160. Feasibility of adjuvant laparoscopic hyperthermic intraperitoneal chemotherapy in a short stay setting in patients with colorectal cancer at high risk of peritoneal carcinomatosis
  161. Toward Online Adaptive Hyperthermia Treatment Planning: Correlation Between Measured and Simulated Specific Absorption Rate Changes Caused by Phase Steering in Patients
  162. Meta-Analysis of Tumor Fractionation Sensitivities Based on Clinical Data
  163. Treatment and prognostic factors of radiation-associated angiosarcoma (RAAS) after primary breast cancer: A systematic review
  164. Feasibility of Electric Property Tomography of pelvic tumors at 3T
  165. Quantifying the Combined Effect of Radiation Therapy and Hyperthermia in Terms of Equivalent Dose Distributions
  166. EP-1762: Optimization of bladder hyperthermia treatment
  167. Novel Multisensor Probe for Monitoring Bladder Temperature During Locoregional Chemohyperthermia for Nonmuscle-Invasive Bladder Cancer: Technical Feasibility Study
  168. Fast thermal simulations and temperature optimization for hyperthermia treatment planning, including realistic 3D vessel networks
  169. Novel multi-sensor probe for monitoring bladder temperature during loco-regional chemo-hyperthermia for non-muscle invasive bladder cancer: technical feasibility study
  170. CSI-EPT: A novel contrast source approach to MRI based electric properties tomography and patient-specific SAR
  171. Thermal modelling using discrete vasculature for thermal therapy: A review
  172. Cell survival and radiosensitisation: Modulation of the linear and quadratic parameters of the LQ model
  173. PD-0585: Dose escalation by adding hyperthermia: a modelling study
  174. Should hyperthermia be included in the benefit catalogue for oncologic indications?
  175. EMF methods for hyperthermia
  176. Guideline for the clinical application, documentation and analysis of clinical studies for regional deep hyperthermia
  177. Specific absorption rate intersubject variability in 7T parallel transmit MRI of the head
  178. Dose-Guided Radiotherapy: Potential Benefit of Online Dose Recalculation for Stereotactic Lung Irradiation in Patients With Non-Small-Cell Lung Cancer
  179. Automatic delineation of body contours on cone-beam CT images using a delineation booster
  180. Radiosensitization with Hyperthermia and Chemotherapeutic Agents: Effects on Linear-Quadratic Parameters of Radiation Cell Survival Curves
  181. Concerning the final report “Hyperthermia: a systematic review” of the Ludwig Boltzmann Institute for Health Technology Assessment, Vienna, March 2010
  182. Quality assurance for clinical studies in regional deep hyperthermia
  183. 5033 POSTER Re-irradiation Plus Hyperthermia for 415 Patients With Recurrent Breast Cancer in Previously Irradiated Area – the Amsterdam + Tilburg Experience
  184. Uncertainty in hyperthermia treatment planning: the need for robust system design
  185. Improved power steering with double and triple ring waveguide systems: The impact of the operating frequency
  186. 3D versus 2D steering in patient anatomies: A comparison using hyperthermia treatment planning
  187. Radiotherapy combined with hyperthermia for primary malignant melanomas of the esophagus
  188. Optimization in hyperthermia treatment planning: The impact of tissue perfusion uncertainty
  189. The impact of the waveguide aperture size of the 3D 70 MHz AMC-8 locoregional hyperthermia system on tumour coverage
  190. Cryoablation induces greater inflammatory and coagulative responses than radiofrequency ablation or laser induced thermotherapy in a rat liver model
  191. 452 Re-irradiation plus hyperthermia for recurrent breast cancer gives high local response and locoregional control
  192. SAR deposition by curved CFMA-434 applicators for superficial hyperthermia: Measurements and simulations
  193. Comparison of two different 70 MHz applicators for large extremity lesions: Simulation and application
  194. Elective re-irradiation and hyperthermia following resection of persistent locoregional recurrent breast cancer: A retrospective study
  195. Body Conformal Antennas for Superficial Hyperthermia: The Impact of Bending Contact Flexible Microstrip Applicators on Their Electromagnetic Behavior
  196. Quantification of the Contribution of Hyperthermia to Results of Cervical Cancer Trials: In Regard to Plataniotis and Dale (Int J Radiat Oncol Biol Phys 2009;73:1538–1544)
  197. Characteristics and performance evaluation of the capacitive Contact Flexible Microstrip Applicator operating at 70 MHz for external hyperthermia
  198. Accelerated ray tracing for radiotherapy dose calculations on a GPU
  199. PELVIC MALIGNANCIES TREATED WITH THE NEW 3D LOCOREGIONAL HYPERTHERMIA SYSTEM (AMC-8)
  200. Acceleration of high resolution temperature based optimization for hyperthermia treatment planning using element grouping
  201. Characteristics and performance evaluation of the capacitive Contact Flexible Microstrip Applicator operating at 70 MHz for external hyperthermia
  202. FDTD simulations to assess the performance of CFMA-434 applicators for superficial hyperthermia
  203. Preoperative chemoradiation combined with regional hyperthermia for patients with resectable esophageal cancer
  204. Improving locoregional hyperthermia delivery using the 3-D controlled AMC-8 phased array hyperthermia system: A preclinical study
  205. Chest wall radiation associated sarcomas are sensitive to reirradiation and hyperthermia
  206. Relation between body size and temperatures during locoregional hyperthermia of oesophageal cancer patients
  207. Artefacts in intracavitary temperature measurements during regional hyperthermia
  208. Theoretical comparison of intraluminal heating techniques
  209. Hyperthermia, cisplatin and radiation trimodality treatment: A promising cancer treatment? A review from preclinical studies to clinical application
  210. Delineation of potential hot spots for hyperthermia treatment planning optimisation
  211. On verification of hyperthermia treatment planning for cervical carcinoma patients
  212. Monitoring of response to preoperative chemoradiation in combination with hyperthermia in oesophageal cancer by FDG-PET
  213. Reliability of temperature and SAR measurements at oesophageal tumour locations
  214. Prospective treatment planning to improve locoregional hyperthermia for oesophageal cancer
  215. Erratum
  216. Monitoring of response to pre-operative chemoradiation in combination with hyperthermia in oesophageal cancer by FDG-PET
  217. 523 Improvement of locoregional hyperthermia treatments of oesophageal cancer using treatment planning
  218. High-resolution temperature-based optimization for hyperthermia treatment planning
  219. On estimation of the temperature maximum in intraluminal or intracavitary hyperthermia
  220. A feasibility study in oesophageal carcinoma using deep loco-regional hyperthermia combined with concurrent chemotherapy followed by surgery
  221. A feasibility study of interstitial hyperthermia plus external beam radiotherapy in glioblastoma multiforme using the multi electrode current source (MECS) system
  222. Three-dimensional controlled interstitial hyperthermia combined with radiotherapy for locally advanced prostate carcinoma—a feasibility study
  223. Determination and validation of the actual 3D temperature distribution during interstitial hyperthermia of prostate carcinoma
  224. Clinical thermometry, using the 27 MHz multi-electrode current-source interstitial hyperthermia system in brain tumours
  225. Modelling individual temperature profiles from an isolated perfused bovine tongue
  226. Evaluation of the Treatment Planning of Interstitial Hyperthermia of Glioblastomas
  227. Spatial steering with quadruple electrodes in 27MHz capacitively coupled interstitial hyperthermia
  228. Temperature measurement errors with thermocouples inside 27 MHz current source interstitial hyperthermia applicators
  229. Comparison of temperature distributions in interstitial hyperthermia: experiments in bovine tongues versus generic simulations
  230. Thermal properties of capacitively coupled electrodes in interstitial hyperthermia
  231. Tests of the geometrical description of blood vessels in a thermal model using counter-current geometries
  232. Accuracy of geometrical modelling of heat transfer from tissue to blood vessels
  233. Design of applicators for a 27 MHz multielectrode current source interstitial hyperthermia system; impedance matching and effective power
  234. Implications of using thermocouple thermometry in 27 MHz capacitively coupled interstitial hyperthermia
  235. Spatial temperature control with a 27 MHz current source interstitial hyperthermia system
  236. The influence of vasculature on temperature distributions in MECS interstitial hyperthermia: Importance of longitudinal control
  237. Numerical analysis of capacitively coupled electrodes for interstitial hyperthermia
  238. A description of discrete vessel segments in thermal modelling of tissues
  239. Dose uniformity in MECS interstitial hyperthermia: the impact of longitudinal control in model anatomies
  240. Basics of Thermal Models
  241. Principles of Treatment Planning
  242. The theoretical and experimental evaluation of the heat balance in perfused tissue
  243. Dose uniformity in scanned focused ultrasound hyperthermia
  244. Thermal Model Verification in Interstitial Hyperthermia
  245. Thermal Modeling of Vascular Patterns and Their Impact on Interstitial Heating Technology and Temperature Monitoring
  246. Temperature and SAR measurements in deep-body hyperthermia with thermocouple thermometry
  247. Future Developments in Respect of Thermal Modeling, Treatment Planning, and Treatment Control for Interstitial Hyperthermia
  248. Temperature uniformity during hyperthermia: the impact of large vessels
  249. Interstitial heating: experiments in artificially perfused bovine tongues
  250. A perfusion technique for tongues to be used in bioheat transfer studies
  251. Experimental verification of bioheat transfer theories: measurement of temperature profiles around large artificial vessels in perfused tissue
  252. Generation of a fast and homogeneous temperature step
  253. Generation of a rapid step in the temperature of a papillary muscle
  254. Evaluation of actual 3D temperature distributions using a discrete vasculature (DiVa) thermal model
  255. Test of the MECS IHT system with bovine tongues